Effects of Zoledronic Acid on Prostate Cells
Author Information
Author(s): Goffinet M, Thoulouzan M, Pradines A, Lajoie-Mazenc I, Weinbaum Carolyn, Faye JC, Séronie-Vivien S
Primary Institution: Inserm U563, Centre de Physiopathologie de Toulouse Purpan, Institut Claudius Regaud, Toulouse, France
Hypothesis
Does zoledronic acid impair protein geranyl-geranylation in prostatic cells?
Conclusion
Zoledronic acid inhibits protein geranyl-geranylation in prostatic cells, affecting their biological activity.
Supporting Evidence
- Zoledronic acid inhibited the proliferation of all three prostatic cell lines in a dose-dependent manner.
- The non-tumoral cell line PNT1-A was affected most by zoledronic acid treatment.
- Geranyl-geraniol was able to reverse the inhibition of proliferation caused by zoledronic acid.
Takeaway
Zoledronic acid is a medicine that can stop certain cells in the prostate from growing by blocking a process that helps proteins work properly.
Methodology
The study used three prostatic cell lines to assess the effects of zoledronic acid on cell proliferation and protein isoprenylation.
Limitations
The exact mechanism of action of zoledronic acid in prostatic cells remains unclear.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website